Catalyst Biosciences Inc (NASDAQ:CBIO)
| 4.56 Delayed Data As of Apr 20 |  0.00 / 0.00%Today’s Change | 4.05 Today|||52-Week Range 8.22 | -27.73% Year-to-Date |
Latest CBIO News | Press Releases
No recent news for Catalyst Biosciences Inc.
Today’s Trading
| Previous close | 4.55 |
| Today’s open | 4.55 |
| Day’s range | 4.50 - 4.72 |
| Volume | 273,708 |
| Average volume (3 months) | 432,889 |
| Market cap | $160.7M |
Data as of 3:59pm ET, 04/20/2021
Growth & Valuation
| Earnings growth (last year) | +36.20% |
| Earnings growth (this year) | +4.85% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 5.78 |
| Price/Book | 1.49 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CSBRChampions Oncology I... | +0.17 | +1.54% |
| DYAIDyadic International... | -0.11 | -2.27% |
| CFRXContraFect Corp | -0.07 | -1.82% |
| EVFMEvofem Biosciences I... | -0.12 | -7.79% |
Data as of 4:00pm ET, 04/20/2021
Financials
| Next reporting date | May 6, 2021 |
| EPS forecast (this quarter) | -$0.64 |
| Annual revenue (last year) | $20.9M |
| Annual profit (last year) | -$56.2M |
| Net profit margin | -268.48% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
